Goldenwell Biotech, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $372.6K | $213.6K |
| FY2022 | — | $268.3K | $46.0K |
| FY2023 | $46.3K | $168.0K | $53.2K |
| FY2024 | $174.0K | $53.3K | $49.4K |
| FY2025 | — | $-85.8K | $26.8K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $372.6K | $213.6K |
| FY2022 | — | $268.3K | $46.0K |
| FY2023 | $46.3K | $168.0K | $53.2K |
| FY2024 | $174.0K | $53.3K | $49.4K |
| FY2025 | — | $-85.8K | $26.8K |